Karabulut, B. Et Al. 2010. Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: A paradigm of synergistic molecular targeting treatment for ovarian cancer. Journal of Experimental and Clinical Cancer Research , vol.29, no.1 .

Karabulut, B., Karaca, B., Varol, U., Muslu, U., Cakar, B., ATMACA İLHAN, H., ... Ksm, A.(2010). Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: A paradigm of synergistic molecular targeting treatment for ovarian cancer. Journal of Experimental and Clinical Cancer Research , vol.29, no.1.

Karabulut, Bulent Et Al. "Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: A paradigm of synergistic molecular targeting treatment for ovarian cancer," Journal of Experimental and Clinical Cancer Research , vol.29, no.1, 2010

Karabulut, Bulent Et Al. "Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: A paradigm of synergistic molecular targeting treatment for ovarian cancer." Journal of Experimental and Clinical Cancer Research , vol.29, no.1, 2010

Karabulut, B. Et Al. (2010) . "Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: A paradigm of synergistic molecular targeting treatment for ovarian cancer." Journal of Experimental and Clinical Cancer Research , vol.29, no.1.

@article{article, author={Bulent Karabulut Et Al. }, title={Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: A paradigm of synergistic molecular targeting treatment for ovarian cancer}, journal={Journal of Experimental and Clinical Cancer Research}, year=2010}